{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:25:41Z","timestamp":1761128741544},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Safety"],"published-print":{"date-parts":[[1993,11]]},"DOI":"10.2165\/00002018-199309050-00002","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T19:11:02Z","timestamp":1236193862000},"page":"325-339","source":"Crossref","is-referenced-by-count":35,"title":["Methotrexate in Juvenile Rheumatoid Arthritis"],"prefix":"10.2165","volume":"9","author":[{"given":"Edward H.","family":"Giannini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Drug Safety"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T09:14:31Z","timestamp":1455009271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00002018-199309050-00002"}},"subtitle":["Do the Benefits Outweigh the Risks?"],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":0,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.2165\/00002018-199309050-00002","relation":{},"ISSN":["0114-5916"],"issn-type":[{"value":"0114-5916","type":"print"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}